Cite
HARVARD Citation
Feng, H. et al. (2019). Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate. Clinical pharmacology in drug development. 8 (7), pp. 962-970. [Online].